Kaplan–Meier analysis showed that higher HDAC4 expression was significantly correlated with shorter overall survival (OS) and progression-free survival (PFS) times in patients with NPC (Fig. 1H, I). The gene discussed is HDAC4; the disease is nasopharyngeal carcinoma.